Cargando…

Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™)

AIM/INTRODUCTION: Studies on a novel point‐of‐care device for nerve conduction study called DPNCheck have been limited to Westerners. We aimed to clarify Japanese normal limits of nerve action potential amplitude (Amp) and conduction velocity by DPNCheck (investigation I), and the validity of DPNChe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirayasu, Kazuhiro, Sasaki, Hideyuki, Kishimoto, Shohei, Kurisu, Seigo, Noda, Koji, Ogawa, Kenichi, Tanaka, Hiroto, Sakakibara, Yumiko, Matsuno, Shohei, Furuta, Hiroto, Arita, Mikio, Naka, Keigo, Nanjo, Kishio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123044/
https://www.ncbi.nlm.nih.gov/pubmed/29430866
http://dx.doi.org/10.1111/jdi.12818
_version_ 1783352779334483968
author Hirayasu, Kazuhiro
Sasaki, Hideyuki
Kishimoto, Shohei
Kurisu, Seigo
Noda, Koji
Ogawa, Kenichi
Tanaka, Hiroto
Sakakibara, Yumiko
Matsuno, Shohei
Furuta, Hiroto
Arita, Mikio
Naka, Keigo
Nanjo, Kishio
author_facet Hirayasu, Kazuhiro
Sasaki, Hideyuki
Kishimoto, Shohei
Kurisu, Seigo
Noda, Koji
Ogawa, Kenichi
Tanaka, Hiroto
Sakakibara, Yumiko
Matsuno, Shohei
Furuta, Hiroto
Arita, Mikio
Naka, Keigo
Nanjo, Kishio
author_sort Hirayasu, Kazuhiro
collection PubMed
description AIM/INTRODUCTION: Studies on a novel point‐of‐care device for nerve conduction study called DPNCheck have been limited to Westerners. We aimed to clarify Japanese normal limits of nerve action potential amplitude (Amp) and conduction velocity by DPNCheck (investigation I), and the validity of DPNCheck to identify diabetic symmetric sensorimotor polyneuropathy (DSPN; investigation II). MATERIALS AND METHODS: For investigation I, 463 non‐neuropathic Japanese participants underwent DPNCheck examinations. Regression formulas calculating the normal limits of Amp and conduction velocity (Japanese regression formulas [JRF]) were determined by quantile regression and then compared with regression formulas of individuals from the USA (USRF). For investigation II, in 92 Japanese diabetes patients, ‘probable DSPN’ was diagnosed and nerve conduction abnormalities (NCA1: one or more abnormalities, and NCA2: two abnormalities in Amp and conduction velocity) were determined. Validity of NCAs to identify ‘probable DSPN’ was evaluated by determining sensitivity, specificity, reproducibility (kappa‐coefficient) and the area under the curve of receiver operating characteristic curves. RESULTS: For investigation I, JRF was different from USRF, and normal limits by JRF were higher than that of USRF. The prevalence of Amp abnormality calculated by JRF was significantly higher than that of USRF. For investigation II, the sensitivity, specificity and reproducibility of NCA1 and NCA2 judged from JRF were 85%, 86% and 0.57, and 43%, 100% and 0.56, respectively. These values of JRF were higher than those of USRF. The area under the curve of JRF (0.89) was larger than USRF (0.82). CONCLUSIONS: A significant difference in the normal limits of nerve conduction parameters by DPNCheck between Japanese and USA individuals was suggested. Validity to identify DSPN of NCAs might improve by changing the judgment criteria from USRF to JRF.
format Online
Article
Text
id pubmed-6123044
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61230442018-09-06 Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™) Hirayasu, Kazuhiro Sasaki, Hideyuki Kishimoto, Shohei Kurisu, Seigo Noda, Koji Ogawa, Kenichi Tanaka, Hiroto Sakakibara, Yumiko Matsuno, Shohei Furuta, Hiroto Arita, Mikio Naka, Keigo Nanjo, Kishio J Diabetes Investig Articles AIM/INTRODUCTION: Studies on a novel point‐of‐care device for nerve conduction study called DPNCheck have been limited to Westerners. We aimed to clarify Japanese normal limits of nerve action potential amplitude (Amp) and conduction velocity by DPNCheck (investigation I), and the validity of DPNCheck to identify diabetic symmetric sensorimotor polyneuropathy (DSPN; investigation II). MATERIALS AND METHODS: For investigation I, 463 non‐neuropathic Japanese participants underwent DPNCheck examinations. Regression formulas calculating the normal limits of Amp and conduction velocity (Japanese regression formulas [JRF]) were determined by quantile regression and then compared with regression formulas of individuals from the USA (USRF). For investigation II, in 92 Japanese diabetes patients, ‘probable DSPN’ was diagnosed and nerve conduction abnormalities (NCA1: one or more abnormalities, and NCA2: two abnormalities in Amp and conduction velocity) were determined. Validity of NCAs to identify ‘probable DSPN’ was evaluated by determining sensitivity, specificity, reproducibility (kappa‐coefficient) and the area under the curve of receiver operating characteristic curves. RESULTS: For investigation I, JRF was different from USRF, and normal limits by JRF were higher than that of USRF. The prevalence of Amp abnormality calculated by JRF was significantly higher than that of USRF. For investigation II, the sensitivity, specificity and reproducibility of NCA1 and NCA2 judged from JRF were 85%, 86% and 0.57, and 43%, 100% and 0.56, respectively. These values of JRF were higher than those of USRF. The area under the curve of JRF (0.89) was larger than USRF (0.82). CONCLUSIONS: A significant difference in the normal limits of nerve conduction parameters by DPNCheck between Japanese and USA individuals was suggested. Validity to identify DSPN of NCAs might improve by changing the judgment criteria from USRF to JRF. John Wiley and Sons Inc. 2018-03-06 2018-09 /pmc/articles/PMC6123044/ /pubmed/29430866 http://dx.doi.org/10.1111/jdi.12818 Text en © 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Hirayasu, Kazuhiro
Sasaki, Hideyuki
Kishimoto, Shohei
Kurisu, Seigo
Noda, Koji
Ogawa, Kenichi
Tanaka, Hiroto
Sakakibara, Yumiko
Matsuno, Shohei
Furuta, Hiroto
Arita, Mikio
Naka, Keigo
Nanjo, Kishio
Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™)
title Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™)
title_full Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™)
title_fullStr Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™)
title_full_unstemmed Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™)
title_short Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point‐of‐Care Sural Nerve Conduction Device (NC‐stat®/DPNCheck™)
title_sort difference in normal limit values of nerve conduction parameters between westerners and japanese people might need to be considered when diagnosing diabetic polyneuropathy using a point‐of‐care sural nerve conduction device (nc‐stat®/dpncheck™)
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123044/
https://www.ncbi.nlm.nih.gov/pubmed/29430866
http://dx.doi.org/10.1111/jdi.12818
work_keys_str_mv AT hirayasukazuhiro differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck
AT sasakihideyuki differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck
AT kishimotoshohei differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck
AT kurisuseigo differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck
AT nodakoji differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck
AT ogawakenichi differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck
AT tanakahiroto differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck
AT sakakibarayumiko differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck
AT matsunoshohei differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck
AT furutahiroto differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck
AT aritamikio differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck
AT nakakeigo differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck
AT nanjokishio differenceinnormallimitvaluesofnerveconductionparametersbetweenwesternersandjapanesepeoplemightneedtobeconsideredwhendiagnosingdiabeticpolyneuropathyusingapointofcaresuralnerveconductiondevicencstatdpncheck